W. Gigee

557 total citations
13 papers, 431 citations indexed

About

W. Gigee is a scholar working on Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, W. Gigee has authored 13 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Surgery. Recurrent topics in W. Gigee's work include Neuroscience and Neuropharmacology Research (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Neuropeptides and Animal Physiology (2 papers). W. Gigee is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Neuropeptides and Animal Physiology (2 papers). W. Gigee collaborates with scholars based in United States. W. Gigee's co-authors include W. Raab, Wilhelm Raab, R. J. DeGrandpre, G. Schroeder, Richard Wagner, Paul White and E. Lepeschkin and has published in prestigious journals such as Circulation, Circulation Research and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

W. Gigee

13 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Gigee United States 11 172 75 68 45 45 13 431
Wilhelm Raab United States 11 255 1.5× 62 0.8× 72 1.1× 19 0.4× 47 1.0× 13 501
Aado Vendsalu Sweden 6 98 0.6× 69 0.9× 91 1.3× 51 1.1× 73 1.6× 9 422
E. F. Woods United States 14 305 1.8× 108 1.4× 57 0.8× 58 1.3× 33 0.7× 37 634
R. W. Sevy United States 11 145 0.8× 59 0.8× 50 0.7× 21 0.5× 59 1.3× 34 396
Herman B. Daniell United States 9 143 0.8× 88 1.2× 40 0.6× 50 1.1× 18 0.4× 15 414
B.F. Robinson United Kingdom 6 192 1.1× 62 0.8× 73 1.1× 22 0.5× 56 1.2× 7 419
D. Race Australia 12 291 1.7× 57 0.8× 47 0.7× 29 0.6× 23 0.5× 21 565
Mckeen Cattell United States 10 151 0.9× 73 1.0× 65 1.0× 32 0.7× 14 0.3× 25 483
B Garthoff Germany 9 187 1.1× 126 1.7× 85 1.3× 82 1.8× 27 0.6× 18 423
Kwan Eun Kim United States 7 120 0.7× 57 0.8× 51 0.8× 39 0.9× 53 1.2× 7 371

Countries citing papers authored by W. Gigee

Since Specialization
Citations

This map shows the geographic impact of W. Gigee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Gigee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Gigee more than expected).

Fields of papers citing papers by W. Gigee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Gigee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Gigee. The network helps show where W. Gigee may publish in the future.

Co-authorship network of co-authors of W. Gigee

This figure shows the co-authorship network connecting the top 25 collaborators of W. Gigee. A scholar is included among the top collaborators of W. Gigee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Gigee. W. Gigee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Raab, W. & W. Gigee. (1965). URINARY 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN ISCHEMIC HEART DISEASE AND IN UREMIA. The American Journal of the Medical Sciences. 250(5). 547–553. 7 indexed citations
2.
Raab, Wilhelm, et al.. (1961). Sympathogenic origin and antiadrenergic prevention of stress-induced myocardial lesions∗. The American Journal of Cardiology. 8(2). 203–211. 86 indexed citations
3.
Raab, W., et al.. (1960). Influence of muscular training and of catecholamines on cardiac acetylcholine and cholinesterase.. PubMed. 129. 201–15. 24 indexed citations
4.
Raab, W. & W. Gigee. (1958). Uptake and Breakdown of Catecholamines in Vascular Tissue. Angiology. 9(5). 283–289. 15 indexed citations
5.
Raab, W. & W. Gigee. (1957). Influence of nicotine and hexamethonium on the catecholamine content of the dog's heart.. PubMed. 112(3-4). 297–304. 6 indexed citations
6.
Raab, W., et al.. (1956). Cardiotoxic Effects of Hypercatecholemia in Renal Insufficiency. Circulation. 14(4). 614–621. 14 indexed citations
7.
Raab, W., et al.. (1956). VASCULAR REACTIVITY AND ELECTROLYTES IN NORMAL AND TOXEMIC PREGNANCY PATHOGENIC CONSIDERATIONS AND A DIAGNOSTIC PRE-TOXEMIA TEST*. The Journal of Clinical Endocrinology & Metabolism. 16(9). 1196–1216. 50 indexed citations
8.
Raab, Wilhelm & W. Gigee. (1955). Norepinephrine and Epinephrine Content of Normal and Diseased Human Hearts. Circulation. 11(4). 593–603. 43 indexed citations
9.
Raab, W. & W. Gigee. (1955). Specific Avidity of the Heart Muscle to Absorb and Store Epinephrine and Norepinephrine. Circulation Research. 3(6). 553–558. 73 indexed citations
10.
Raab, Wilhelm & W. Gigee. (1954). Total Urinary Catechol Excretion in Cardiovascular and Other Clinical Conditions. Circulation. 9(4). 592–599. 31 indexed citations
11.
Raab, W. & W. Gigee. (1953). Die Katecholamine des Herzens. Naunyn-Schmiedeberg s Archives of Pharmacology. 219(3). 248–62. 18 indexed citations
12.
Raab, W., et al.. (1952). Pressor Effects of Epinephrine, Norepinephrine and Desoxycorticosterone Acetate (DCA) Weakened by Sodium Withdrawal. Circulation. 6(3). 373–377. 41 indexed citations
13.
Raab, W. & W. Gigee. (1951). Concentration and Distribution of "Encephalin" in the Brain of Humans, and Animals. Experimental Biology and Medicine. 76(1). 97–100. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026